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The reversible phosphorylation of proteins is accomplished by opposing activities of kinases and 
phosphatases. Relatively few protein serine/threonine phosphatases (PSPs) control the specific 
dephosphorylation of thousands of phosphoprotein substrates. Many PSPs, exemplified by protein 
phosphatase 1 (PP1) and PP2A, achieve substrate specificity and regulation through combinato-
rial interactions between conserved catalytic subunits and a large number of regulatory subunits. 
Other PSPs, represented by PP2C and FCP/SCP, contain both catalytic and regulatory domains 
within the same polypeptide chain. Here, we discuss biochemical and structural investigations 
that advance the mechanistic understanding of the three major classes of PSPs, with a focus on 
PP2A.The concept of protein phosphorylation, discovered by 
Edmond Fischer and Edwin Krebs, arose from the dem-
onstration of a dual requirement for ATP and a “converting 
enzyme” (subsequently named phosphorylase kinase) in the 
in vitro conversion of phosphorylase b to phosphorylase a 
(Fischer and Krebs, 1955; Krebs and Fischer, 1956; Krebs et 
al., 1958). This process involved the transfer of a phosphate 
group from ATP to phosphorylase b, and the resulting phos-
phorylase a was found to be a phosphoprotein (Krebs and 
Fischer, 1956; Sutherland and Wosilait, 1955). Intriguingly, 
the enzyme that converts phosphorylase a back to b, called 
the “PR enzyme” (phosphorylase phosphatase), had been 
reported a decade earlier (Cori and Green, 1943), although 
the chemical nature of the reaction remained enigmatic 
until inorganic phosphate was found to be a product of the 
reaction (Krebs and Fischer, 1956; Sutherland and Wosilait, 
1955).
Decades of research since those initial discoveries have 
shown that reversible phosphorylation of proteins, executed 
by kinases and phosphatases, constitutes a major form of 
signaling and an essential mechanism of regulation in all liv-
ing organisms. In eukaryotic cells, phosphorylation mainly 
occurs on three hydroxyl-containing amino acids, serine, 
threonine, and tyrosine, of which serine is the predominant 
target. Proteomic analysis of 6600 phosphorylation sites on 
2244 human proteins revealed that phosphoserine (pSer), 
phosphothreonine (pThr), and phosphotyrosine (pTyr) account 
for 86.4%, 11.8%, and 1.8%, respectively, of the phospho-
rylated amino acids (Olsen et al., 2006). These numbers are 
in good agreement with a previous study in which radio-
active isotope (32P)-labeled phosphoproteins from chicken 
cells were isolated, acid hydrolyzed, and analyzed by two-
dimensional electrophoresis (Hunter and Sefton, 1980). The 
fully sequenced human genome is thought to contain 518 
putative protein kinases (Johnson and Hunter, 2005; Lander 468 Cell 139, October 30, 2009 ©2009 Elsevier Inc.et al., 2001; Venter et al., 2001) that can be classified into 
two families: 90 tyrosine (Tyr) kinases (PTKs) and 428 serine/
threonine (Ser/Thr) kinases (PSKs). The exquisite specific-
ity of signaling and the reversible nature of phosphorylation 
seem to suggest that there would be similar numbers of pro-
tein phosphatases in the human genome. Surprisingly, how-
ever, there are only 107 putative protein Tyr phosphatases 
(PTPs) (Alonso et al., 2004) and far fewer protein Ser/Thr 
phosphatases (PSPs) (?30). Whereas the numbers of PTKs 
and PTPs roughly match each other, the number of catalytic 
subunits of PSPs is an order of magnitude lower than that 
of PSKs. As will be clear from the discussion below, this 
dichotomy can be explained by the combinatorial formation 
of PSP holoenzymes from a shared catalytic subunit and a 
large number of regulatory subunits.
PSPs comprise three major families: phosphoprotein phos-
phatases (PPPs), metal-dependent protein phosphatases 
(PPMs), and the aspartate-based phosphatases represented 
by FCP/SCP (TFIIF-associating component of RNA polymerase 
II CTD phosphatase/small CTD phosphatase) (Figure 1). For 
several members of the PPP family, the catalytic subunit asso-
ciates with a great variety of regulatory subunits. Representa-
tive members of the PPP family include protein phosphatase 
1 (PP1), PP2A, PP2B (commonly known as calcineurin), PP4, 
PP5, PP6, and PP7 (Figure 1). The PPM family includes pro-
tein phosphatases dependent on manganese/magnesium 
ions (Mn2+/Mg2+), such as PP2C and pyruvate dehydrogenase 
phosphatase. In contrast to PPP, members of the PPM fam-
ily do not have regulatory subunits but contain instead addi-
tional domains and conserved sequence motifs that may help 
determine substrate specificity. For both PPP and PPM, metal 
ions play a catalytic and central role through the activation of a 
water molecule for the dephosphorylation reaction. In contrast, 
FCP/SCP uses an aspartate-based catalysis mechanism. The 
only known substrate for FCP/SCP is the C-terminal domain 
Figure 1. The Three Families of Protein 
Serine/Threonine Phosphatases
Protein serine/threonine phosphatases (PSPs) 
can be categorized into three families—phospho-
protein phosphatases (PPPs), metal-dependent 
protein phosphatases (PPMs), and aspartate-
based phosphatases such as FCP (TFIIF-asso-
ciating component of RNA polymerase II CTD 
phosphatase) and SCP (small CTD phosphatase). 
Representative members of each family are pre-
sented here. The catalytic core domains of each 
protein are indicated below the diagram. Signature 
sequence motifs are labeled above the diagram. 
Residues that contribute to metal coordination 
and phosphate binding are colored in red and blue, 
respectively. The PPP family contains three char-
acteristic sequence motifs within the conserved 
30 kD catalytic domain: GDxHG, GDxVDRG, and 
GNHE (G, glycine; D, aspartic acid; x, any amino 
acid; H, histidine; V, valine; R, arginine; N, aspar-
agine; E, glutamic acid). BBH, CNB-binding helix; 
CTD, carboxy-terminal domain; CBD, Ca2+-calm-
odulin-binding motif; AI, autoinhibitory sequence; 
TPR, tetratricopeptide repeat; FCPH, FCP-ho-
mology domain. The accession codes for the 
proteins depicted are as follows: PP1α, P62136; 
PP2Aα, P67775; PP2Bα, Q08209; PP4, P60510; 
PP5, P53041; PP6, O00743; PP7, Q9FN02; PP2C, 
S87759; Fcp1α, NP_004706; Scp1, NP_067021. 
All proteins here are from Homo sapiens except for 
PP7 (from the model plant Arabidopsis thaliana).(CTD) of RNA polymerase II, which contains tandem repeats of 
a serine-rich heptapeptide. The conserved structural core of 
FCP/SCP is the FCP homology (FCPH) domain (Figure 1). FCPs, 
but not SCPs, contain a BRCT (BRCA1 C-terminal domain like) 
domain that is C-terminal to the FCPH domain.
Over the last two decades of investigation, cellular functions 
of PSPs have been documented with increasing detail. An ear-
lier emphasis on functional characterization has recently been 
complemented by biochemical and structural investigations of 
all three major families of PSPs, giving rise to major advances 
in mechanistic understanding. The cellular and physiological 
functions of PSPs have been extensively discussed in recent 
reviews (Ceulemans and Bollen, 2004; Cohen, 2002, 2004; 
Cohen et al., 2005; Gallego and Virshup, 2005; Hinds and San-
chez, 2008; Janssens et al., 2008; Kamenski et al., 2004; Lu 
and Wang, 2008; Moorhead et al., 2007). Therefore, this review 
will focus on the molecular mechanisms elucidated by recent 
biochemical and structural studies.
Protein Phosphatase 1
PP1 is a major protein Ser/Thr phosphatase and is ubiquitously 
expressed in all eukaryotic cells. PP1 figures prominently in a wide 
range of cellular processes, including meiosis and cell division, 
apoptosis, protein synthesis, metabolism, cytoskeletal reorgani-
zation, and the regulation of membrane receptors and channels 
(Ceulemans and Bollen, 2004; Cohen, 2002). Commensurate with 
its myriad functions, the many forms of PP1 collectively exhibit 
broad substrate specificity. However, each assembled and func-
tional PP1 enzyme is thought to display stringent substrate speci-
ficity and elicits specific biological responses.
Each functional PP1 enzyme consists of a catalytic subunit 
and a regulatory subunit (R subunit). The catalytic subunit of 
PP1 is highly conserved among all eukaryotes, with approxi-mately 70% or greater protein sequence identity in any pair-
wise alignment. These sequences support a conserved fold 
and a similarly positioned active site for all members of the 
PPP family. At least 100 putative PP1-binding R subunits have 
been identified, with many more expected to be found (Cohen, 
2004; Moorhead et al., 2007). Analysis of known R subunits 
in diverse eukaryotic lineages suggests an explosive growth 
in the number of R subunits concurrent with the evolution of 
multicellular organisms (Ceulemans et al., 2002). These R sub-
units may target the PP1 catalytic subunit to specific subcel-
lular compartment, modulate substrate specificity, or serve 
as substrates themselves. Thus, the interactions between the 
catalytic subunit and specific R subunits are central to the 
functions of PP1.
The catalytic subunit of PP1 adopts a compact α/β fold, 
with a β sandwich wedged between two α-helical domains 
(Egloff et al., 1995; Goldberg et al., 1995) (Figure 1A). Two 
metal ions, identified as Mn2+ and Fe2+ (iron), are located in 
the active site at the three-way joint of the β sandwich and 
the two helical domains. Coordination of these two metal 
ions is provided by three histidines, two aspartic acids, and 
one asparagine. These residues are highly conserved in all 
members of the PPP family (Figure 2B), suggesting a com-
mon mechanism of metal-catalyzed reaction in the protein 
family. The two metal ions are thought to bind and activate 
a water molecule, which initiates a nucleophilic attack on the 
phosphorous atom (Egloff et al., 1995; Goldberg et al., 1995). 
Three shallow surface grooves roughly follow the domain 
boundaries and converge at the catalytic center, forming a 
Y-shaped surface feature (Figure 2A). Tumor-inducing toxins 
such as microcystin and okadaic acid associate tightly with 
the active site through interactions with amino acids on the 
surface loops of the catalytic center.Cell 139, October 30, 2009 ©2009 Elsevier Inc. 469
Early studies suggested that most R subunits contain the 
sequence motif RVxF/W (R, arginine; V, valine; x, any amino 
acid; F, phenylalanine; W, tryptophan). This notion was sup-
ported by the crystal structure of PP1 bound to a peptide con-
taining the sequence RRVSFA (S, serine; A, alanine) (Egloff et 
al., 1997). The valine and phenylalanine residues of the peptide 
stack against hydrophobic amino acids on the surface of PP1, 
whereas the side chain of the first, but not the second, arginine 
residue makes hydrogen bonds to PP1. Subsequent studies 
focused on the identification and improvement of the consen-
sus peptide sequence (Croci et al., 2003; Enz and Croci, 2003; 
Wakula et al., 2003). Most of the R subunits of PP1 were thought 
to contain a surface motif of [RK][X]0-1[VI]X[F/W] (I, isoleucine) 
(Wakula et al., 2003). More recently, systematic analysis of the 
docking peptides that combined biochemistry with molecu-
lar dynamics gave rise to a refined consensus sequence of 
[H/K/R][A/C/H/K/M/N/Q/R/S/T/V][V][C/H/K/N/Q/R/S/T][F/W] 
(H, histidine; K, lysine; C, cystein; M, methionine; N, asparag-
ine; Q, glutamine; T, threonine) (Meiselbach et al., 2006). This 
consensus sequence allowed the accurate prediction and 
experimental confirmation of several previously unknown PP1-
binding proteins and reconciled a body of observations. Within 
this consensus sequence, the most conserved valine and phe-
nylalanine/tryptophan residues appear to anchor the binding of 
the R subunit to PP1, whereas the other residues provide the 
needed specificity for recognizing different R subunits.
How do R subunits help improve substrate specificity? Struc-
tural analysis of PP1 bound to the myosin phosphatase target-
ing subunit (MYPT1) protein revealed a tantalizing clue (Terrak 
et al., 2004). MYPT1 associates with PP1 using a tripartite bind-
ing mode. Within MYPT1, a TKVKF sequence interacts with 
the conserved hydrophobic surface of PP1, an ankyrin repeat 
domain caps the C terminus of PP1, and a hydrophobic N-ter-
minal helix docks onto the surface of PP1 (Figure 2C). Although 
the clasping of PP1 by MYPT1 results in no apparent confor-
mational changes, MYPT1 binding does modify the Y-shaped 
surface groove surrounding the catalytic center of PP1. This was 
thought to enhance substrate specificity by introducing a new 
recognition surface for the substrate protein (Terrak et al., 2004). 
Consistent with this notion, the ankyrin repeats of MYPT1 are 
important for enhanced substrate specificity for myosin despite 
relatively weak binding between myosin and isolated ankyrin 
repeats (Hirano et al., 1997). A definitive proof of this notion 
requires additional biochemical and biophysical investigation 
that involves the substrate protein. Comprehensive mechanistic 
understanding of PP1 will likely require the structural elucidation 
of PP1 bound to different classes of R subunits whose functions 
have been biochemically characterized.
The phosphatase activity of PP1 is regulated by a number of 
endogenous inhibitory proteins such as inhibitor-1 (I-1) (Nimmo 
and Cohen, 1978), inhibitor-2 (I-2) (Foulkes and Cohen, 1980), 
CPI-17 (Eto et al., 1997), and DARPP-32 (Walaas and Green-
gard, 1991). Specific inhibition of PP1 by I-1 and DARPP-32 
requires phosphorylation of a conserved threonine residue at 
the N termini of the inhibitory proteins, which is thought to bind 
the active site of PP1 (Desdouits et al., 1995). Despite sequence 
conservation, PP2A and PP2B are not sensitive to inhibition by 
I-1 or I-2, and this characteristic was the basis for classification 470 Cell 139, October 30, 2009 ©2009 Elsevier Inc.of type 1 (PP1) versus type 2 phosphatases (Ingebritsen and 
Cohen, 1983). By analogy with the PP1 inhibitors, the endog-
enous inhibitors of PP2A were named I1
PP2A and I2
PP2A (Li et al., 
1995) and were found to be putative HLA class II-associated 
protein I (PHAP-I) (Li et al., 1996a) and SET (Li et al., 1996b), 
respectively. The mechanism by which PP2A is inhibited by 
PHAP-I and SET remains to be elucidated.
Calcineurin/Protein Phosphatase 2B
Calcineurin (also known as protein phosphatase 2B or PP2B) 
plays an important role in numerous calcium-dependent bio-
logical processes, including neurodevelopment and memory, 
immune response, cardiac hypertrophy, signal transduction, 
Figure 2. Structure and Mechanism of Protein Phosphatase 1
(A) Structure of the catalytic subunit (blue) of protein phosphatase 1 (PP1) 
bound to okadaic acid (OA, yellow ball and stick). A Y-shaped surface groove 
(pink) is defined by the three domains of PP1. The two metal ions (red spheres) 
are Mn2+ (manganese) and Fe2+ (iron).
(B) Conserved coordination of the binuclear metal center in the PPP family 
phosphatases. The metal-binding scheme of PP1 where six highly conserved 
amino acids bind to the two metal ions is indicated on the left. The corre-
sponding metal-binding residues from other PPP family members are shown 
on the right.
(C) Structure of the PP1 catalytic domain (blue) bound to the regulatory sub-
unit myosin phosphatase targeting subunit (MYPT1) protein (green). Three 
elements of MYPT1 are involved in the interactions: a VxF (V, valin; x, any 
amino acid; F, phenylalanine) motif that binds to the conserved hydrophobic 
surface of PP1, an ankyrin repeat domain that caps the C terminus of PP1, 
and a hydrophobic N-terminal helix that docks onto the surface of PP1. (Inset) 
A close-up view of the recognition of the VxF motif by PP1.
All structural figures were prepared with PyMol (DeLano, 2002).
Figure 3. Structure and Mechanism of 
Calcineurin
(A) Structure of free calcineurin (also called PP2B), 
which consists of calcineurin A (CNA, blue) and cal-
cineurin B (CNB, gold). The CNB-binding helix (BBH) 
of CNA and the two calmodulin (CaM)-like domains 
of CNB together form a composite surface. The au-
toinhibitory loop forms an α helix and binds the active 
site of the phosphatase, blocking substrate access. 
The two catalytic metal ions and the four calcium at-
oms are colored red and green, respectively.
(B) The FKBP12-FK506 complex binds to the com-
posite surface formed by CNB and the BBH. This 
binding is thought to inhibit calcineurin-mediated 
dephosphorylation of nuclear factor of activated T 
cell (NFAT), a transcription factor, ultimately resulting 
in the suppression of T cell activation. FK506 (yellow) 
directly interacts with residues from both CNB and 
the BBH domain, explaining why interaction between 
calcineurin and FKBP12 requires FK506. FKBP12 
(magenta) interacts with both the phosphatase do-
main and the BBH-CNB composite surface.
(C) Structure of calcineurin bound to the cyclophi-
lin-cyclosporin A complex.
(D) The substrate peptide PxIxIT (P, proline; x, any 
amino acid; I, isoleucine; T, threonine) binds to a 
surface groove on CNA through β-augmentation, 
where the peptide substrate forms a β strand at 
the edge of a β sheet in calcineurin. (Inset) The 
side chains of the proline and isoleucine residues 
in the PxIxIT motif interact with hydrophobic ami-
no acids on the surface of CNA.
(E) A conserved substrate-binding site on PP1 and 
calcineurin. The surface groove of CNA occupied 
by the PxIxIT peptide corresponds to that of PP1 
bound by the RVxF peptide.and muscle development (Rusnak and Mertz, 2000). Calcineu-
rin consists of a catalytic subunit (calcineurin A or CNA) and 
a regulatory subunit (calcineurin B or CNB). CNA contains an 
N-terminal phosphatase domain, followed by a CNB-binding 
helical domain, a calcium (Ca2+)-calmodulin-binding motif, and 
an autoinhibitory element (Figure 1). Calcineurin is inactive 
alone and only gains phosphatase activity upon association 
with Ca2+-calmodulin (Ca2+-CaM).
The mechanism of calcineurin autoinhibition was revealed by 
its crystal structure (Kissinger et al., 1995), which showed that the 
autoinhibitory element forms an α helix and blocks access to the 
catalytic center (Figure 3A). The autoinhibitory element interacts 
with surface amino acids of the phosphatase domain through a 
combination of hydrogen bonds and van der Waals contacts. This 
structural feature suggests that displacement of the autoinhibi-
tory element may be required for the activation of the protein. The 
phosphatase domain of CNA is structurally similar to the catalytic 
subunit of PP1, with the same pattern of metal ion coordination 
(Griffith et al., 1995; Kissinger et al., 1995). The two metal ions 
associated with the protein were identified as Zn2+ (zinc) and Fe3+. 
CNB consists of a pair of Ca2+-binding domains, each contain-
ing two EF-hand motifs. All four calcium-binding sites in CNB are 
fully loaded, with each calcium ion coordinated by five oxygen 
atoms—four from side chains and one from a main chain carbo-
nyl group. The two Ca2+-binding domains of CNB are organized 
around the CNB-binding helical domain (BBH).
The hydrophobic face of the BBH helix is buried in a greasy 
pocket on the surface of CNB, whereas the other exposed 
face of BBH forms a composite binding surface with neigh-boring residues of CNB (Figure 3A). Both the FKBP12-FK506 
(Griffith et al., 1995; Kissinger et al., 1995) and the cyclophilin 
A (CyPA)-cyclosporin A (CsA) (Huai et al., 2002; Jin and Har-
rison, 2002) complexes associate with this surface through a 
similar set of interactions (Figures 3B and 3C), despite a lack of 
structural homology between these two complexes. Binding by 
these immunosuppressant complexes is thought to inhibit cal-
cineurin-mediated dephosphorylation of the transcription factor 
nuclear factor of activated T cell (NFAT), ultimately resulting in 
the suppression of T cell activation. In both cases, the immuno-
suppressants make direct interactions with residues from both 
CNB and the BBH domain. This observation explains why inter-
actions between calcineurin and immunophilins strictly depend 
on the presence of the immunosuppressants. The immunophi-
lins directly interact with both the phosphatase domain and 
the BBH-CNB composite surface, with approximately 80% of 
the interface residues of calcineurin involved in binding to both 
FKBP12-FK506 and CyPA-CsA (Ke and Huai, 2003). Differences 
in hydrogen bond interactions appear to dictate the specific rec-
ognition of distinct immunosuppressant complexes, and these 
differences provide plausible explanation for the observed immu-
nosuppressant-specific phenotypes. For example, the mutation 
of tyrosine 341 to phenylalanine (Y341F) in calcineurin rendered 
T lymphocytes and yeast cells resistant to CsA, but not to FK506 
(Cardenas et al., 1995; Zhu et al., 1996). In the structure, CsA, but 
not FK506, makes two hydrogen bonds to the hydroxyl group of 
tyrosine 341 in calcineurin; the Y341F mutation eliminates these 
interactions, likely resulting in the weakened interaction between 
the CyPA-CsA complex and calcineurin.Cell 139, October 30, 2009 ©2009 Elsevier Inc. 471
How does the immunophilin-immunosuppressant complex 
inhibit the phosphatase activity of calcineurin? An intuitive 
explanation is that the relatively close proximity of the bound 
immunophilin-immunosuppressant complex to the catalytic 
center of calcineurin may hinder substrate access (Griffith et 
al., 1995). It is also possible that the composite surface above 
BBH, which is occupied by the immunosuppressant complex, 
is involved in substrate recognition. In addition, activation of 
calcineurin requires Ca2+-CaM; yet the Ca2+-CaM-binding ele-
ment in the protein is positioned C-terminal to BBH (Figure 1). 
Binding of the immunosuppressant complex to the composite 
surface involving the BBH domain may negatively affect the 
ability of Ca2+-CaM to activate the phosphatase domain of 
calcineurin.
How does calcineurin recognize substrate proteins? Exten-
sive studies of calcineurin substrates in yeast and mammalian 
cells, especially on NFAT1, revealed a consensus recognition 
motif of PxIxIT (P, proline) (Bultynck et al., 2006; Czirjak and 
Enyedi, 2006; Czirjak et al., 2004; Heath et al., 2004; Li et al., 
2004; Roy et al., 2007). Sequence variations within the PxIxIT 
motif results in a wide range of binding affinities—between 
0.5 and 250 µM—to calcineurin, (Li et al., 2007). Structural 
analysis of calcineurin bound to the peptide PVIVIT (V, valine) 
helped to explain the findings of these biochemical studies 
(Li et al., 2007; Takeuchi et al., 2007). The PVIVIT peptide 
forms a β strand with strand β14 of CNA through main chain 
hydrogen bonds (Figure 3D). The side chains of the proline 
and the two isoleucine residues in the PVIVIT motif interact 
with hydrophobic amino acids on the surface of CNA (Figure 
3D), whereas the side chain of threonine makes a hydrogen 
bond to aspartic acid 330 of CNA. In addition to the overall 
structural similarity between PP1 and calcineurin, the surface 
groove of CNA that accommodates the PVIVIT peptide cor-
responds to the surface groove in PP1 that receives the RVxF 
peptide (Figure 3E). Although the presence of the PxIxIT motif 
is necessary for substrate recognition, additional binding ele-
ments from the substrate may be required for the specific 
activity of calcineurin.
How does Ca2+-CaM activate calcineurin? Despite rigor-
ous efforts, a clear answer to this question remains at large. 
A structure of a complex between calcineurin and Ca2+-CaM 
may prove essential for deciphering this puzzle. Nonethe-
less, biochemical and structural investigation has revealed an 
intriguing clue. Although Ca2+-CaM exists as a monomer, the 
Ca2+-CaM-binding motif of calcineurin was shown to induce 
the formation of a stable dimer of Ca2+-CaM (Ye et al., 2008). 
Structural analysis reveals that the Ca2+-CaM-binding motif 
of calcineurin forms a contiguous α helix, which organizes 
two Ca2+-CaM molecules into a head-to-tail dimer (Ye et al., 
2008). This observation suggests that calcineurin may form 
a dimer upon activation by Ca2+-CaM. Consistent with this 
notion, two molecules of calcineurin were found to interact 
with a single peptide substrate through β-augmentation, 
where the peptide substrate forms a β strand at the edge of 
a β sheet in calcineurin (Li et al., 2007). Biochemical analysis 
and modeling studies further suggested that it is possible for 
Ca2+-CaM, calcineurin, and the substrate to form a 2:2:1 com-
plex (Ye et al., 2008).472 Cell 139, October 30, 2009 ©2009 Elsevier Inc.Protein Phosphatase 2A
Protein phosphatase activities that regulate cellular metab-
olism are attributed to two types: type 1, namely PP1, and 
type 2, which consisted of three enzymes called PP2A, PP2B, 
and PP2C (Ingebritsen and Cohen, 1983). In the late 1980s, 
this nomenclature was accepted and the catalytic subunits 
of PP2A were cloned (Arino et al., 1988; Green et al., 1987; 
Stone et al., 1987). PP2A plays an important role in develop-
ment, cell proliferation and death, cell mobility, cytoskeleton 
dynamics, the control of the cell cycle, and the regulation of 
numerous signaling pathways (Janssens and Goris, 2001); it is 
also likely to be an important tumor suppressor (Janssens et 
al., 2005; Mumby, 2007). One of the most abundant enzymes, 
PP2A accounts for up to 1% of total cellular protein in some 
tissues. PP2A is highly conserved from yeast to humans, and 
its regulatory mechanism is extraordinarily complex. Cellu-
lar PP2A exists in two general forms—a heterodimeric core 
enzyme and a heterotrimeric holoenzyme. The PP2A core 
enzyme consists of a scaffold subunit (also known as the A or 
PR65 subunit) and a catalytic subunit (C subunit). The scaf-
fold and the catalytic subunits each have two isoforms, α and 
β, with the α isoform being about 10-fold more abundant than 
the β isoform. The PP2A core enzyme interacts with a vari-
able regulatory subunit to assemble into a holoenzyme. The 
regulatory subunits comprise four families: B (also known as 
B55 or PR55), B′ (B56 or PR61), B′′ (PR48/PR72/PR130), and 
B′′′ (PR93/PR110). Each family consists of two to five isoforms 
that are encoded by different genes; some isoforms have mul-
tiple splice variants. For example, the B′ family contains five 
isoforms, α, β, γ, δ, and ε. The human B′γ isoform has at least 
three different splice variants called γ1, γ2, and γ3. Except for 
subunits of the B′′′ family, all members of these regulatory 
subunit families have been shown to bind directly to the PP2A 
core enzyme. Although highly conserved within the same 
family, these regulatory subunits share little sequence simi-
larity across families, and their expression levels vary greatly 
in different cell types and tissues.
The PP2A Core Enzyme
The PP2A scaffold subunit contains 15 tandem HEAT (hun-
tingtin-elongation-A subunit-TOR) repeats, which form an 
elongated, horseshoe-shaped structure (Groves et al., 1999). 
Each HEAT repeat comprises a pair of antiparallel α heli-
ces, with the interhelical loop composed of highly conserved 
sequences. A contiguous ridge is formed by the 15 interhelical 
loop sequences. Structural analysis revealed that the catalytic 
subunit recognizes the conserved ridge of HEAT repeats 11–15 
(Xing et al., 2006) (Figure 4A). Two tumor-derived missense 
mutations, R418W in the α isoform and V545A in the β isoform 
of the scaffold subunit (Ruediger et al., 2001b; Wang et al., 
1998), map to the interface, suggesting a plausible explanation 
to the observation that these mutations crippled interaction of 
the scaffold with the catalytic subunit (Ruediger et al., 2001a, 
2001b). Although other PPP family members share extensive 
sequence similarity with the catalytic subunit of PP2A, they do 
not associate with the PP2A scaffold subunit. Structural analy-
sis of the interface between the catalytic and scaffold subunits 
provides a satisfying explanation to this observation. Among 
the amino acids of the PP2A catalytic subunit that specifically 
Figure 4. Assembly, Structure, and Mechanisms of PP2A
(A) Structure of the heterodimeric PP2A core enzyme. The catalytic subunit (green) binds to HEAT (huntingtin-elongation-A subunit-TOR) repeats 11–15 of the 
scaffold subunit (gray).
(B) Structure of the heterotrimeric PP2A holoenzyme involving the B′ regulatory subunit. The B′ subunit (yellow) recognizes HEAT repeats 2–8 of the scaffold 
subunit and makes extensive interactions with the catalytic subunit.
(C) The B′ subunit is structurally similar to the scaffold subunit of PP2A and the nuclear transport protein karyopherin. B′ contains eight HEAT-like repeats and 
has a concave surface that may be responsible for substrate recognition.
(D) Structure of a heterotrimeric PP2A holoenzyme harboring the B regulatory subunit. The B subunit (gold) recognizes HEAT repeats 1–7 and makes few inter-
actions with the catalytic subunit.
(E) The B subunit contains an acidic top face for interaction with the microtubule-binding Tau protein. Eight residues (glutamate 27, E27; lysine 48, K48; gluta-
mate 93; glutamate 94; lysine 95; tyrosine 178, Y178; histidine 179, H179; aspartate 197, D197) that are important for binding to Tau are labeled, with their side 
chains in yellow. In addition, a contiguous stretch of seven amino acids (from phenylalanine 84 to leucine 90) important for binding to Tau are indicated only by 
the main chain (yellow). Mutation of these seven amino acids also resulted in compromised binding to Tau.
(F) Conformational flexibility of the scaffold subunit of PP2A. Shown here is a comparison between the scaffold subunit (purple), taken from the core enzyme 
structure, and the scaffold subunit (gray), taken from the B′-containing holoenzyme structure.
(G) Structure of the PP2A methylesterase PME-1 (brown) bound to the heterodimeric PP2A core enzyme. PME-1, which catalyzes the removal of PP2A methyla-
tion, interacts only with the catalytic subunit of PP2A (green).
(H) Conformational changes of PME-1 upon binding to the PP2A core enzyme. A structural comparison of free PME-1 (cyan) with that bound to the PP2A core 
enzyme (brown) shows that helix α4 is shifted in the bound structure, thus allowing the accommodation of the C-terminal peptide of PP2A catalytic subunit.
(I) Formation of an active site in PME-1 upon binding to the PP2A core enzyme. (Inset) Compared to free PME-1, the side chain of histidine 349 (H349) in the 
PP2A-bound PME-1 is translocated by 8 Å, within hydrogen bond distance of aspartate 181 (D181) and serine 156 (S156).Cell 139, October 30, 2009 ©2009 Elsevier Inc. 473
interact with the scaffold subunit, most have been replaced by 
nonconserved amino acids in PP1, PP2B, PP5, and PP7. The 
only exceptions are PP4 and PP6, which contain the majority, 
but not all, of these interface residues.
The catalytic subunit of PP2A is the primary target of a num-
ber of potent tumor-inducing toxins, such as okadaic acid (OA) 
and microcystin-LR (MCLR). OA has an inhibitory constant of 
approximately 0.1 nM for the phosphatase activity of PP2A, 
which is about 100-fold more potent than its inhibitory constant 
for PP1 (MacKintosh et al., 1990). Both OA and MCLR interact 
with a similar set of amino acids surrounding the active site of 
the catalytic subunit (Xing et al., 2006). Structural comparison 
revealed that a hydrophobic cage in the catalytic subunit of 
PP2A that accommodates OA is less well formed in PP1 (Xing 
et al., 2006), which may account for the observed differences 
in inhibition.
The PP2A Holoenzyme
The heterotrimeric PP2A holoenzyme is believed to exhibit 
exquisite substrate specificity as well as spatially and tempo-
rally determined functions. For example, the B′ subunit, but 
not B or B′′, was thought to be specific for interacting with 
shugoshin (Kitajima et al., 2006; Riedel et al., 2006; Tang et 
al., 2006), a centromeric protein required for proper genome 
segregation (Gregan et al., 2008). In contrast, the B, but not 
B′ or B′′, subunit was responsible for dephosphorylation of the 
microtubule-binding protein Tau (Drewes et al., 1993; Gong 
et al., 1994; Xu et al., 2008). Thus structural elucidation of a 
PP2A holoenzyme was expected to unveil major insight into 
how a regulatory subunit facilitates specific PP2A function. The 
structure of the B′-containing PP2A holoenzyme revealed that 
the regulatory subunit makes extensive interactions with both 
the scaffold subunit, through HEAT repeats 2–8, and the cata-
lytic subunit (Cho and Xu, 2006; Xu et al., 2006) (Figure 4B). The 
B′ subunit shows unanticipated structural mimicry to the scaf-
fold subunit and contains eight HEAT-like repeats (Figure 4C).
The structure of the B′ subunit also resembles that of sev-
eral other superhelical proteins, including karyopherin, which 
is involved in transporting proteins through the pores of the 
nuclear envelope, and β-catenin, a component of the Wnt sig-
naling pathway (Figure 4C). In the assembled PP2A holoen-
zyme, the convex surface of B′ associates with the scaffold 
subunit, and the acidic, concave surface is tilted toward the 
active site pocket of the PP2A catalytic subunit. Similar to 
karyopherin and β-catenin (Conti et al., 1998; Graham et al., 
2000), the B′ subunit may use this surface to recognize a sub-
strate protein for its dephosphorylation.
The structure of PP2A holoenzyme harboring the B subunit 
shows that the B subunit contains seven WD40 repeats, a 
β-hairpin handle, and several additional secondary structural 
elements that are located on the top face of the β-propeller 
(Xu et al., 2008) (Figure 4D). The bottom face of the β-propeller 
binds to the ridge of HEAT repeats 3–7, and the β-hairpin 
handle interacts with HEAT repeats 1 and 2. Unlike the PP2A 
holoenzyme containing the B′ subunit, the B subunit makes 
few interactions with the catalytic subunit. A shared feature of 
the two structurally characterized PP2A holoenzymes is that 
the potential substrate-binding site is on the top face of the 
regulatory subunit and close to the active site of the catalytic 474 Cell 139, October 30, 2009 ©2009 Elsevier Inc.subunit. This feature supports the notion that a major function 
of the regulatory subunits is to target substrate phosphopro-
teins to the phosphatase activity of PP2A. However, these two 
families of regulatory subunit are unrelated by sequence or by 
structure, and their specific interactions with the scaffold sub-
unit are quite different.
Substrate Recognition and Targeting
Understanding the function of phosphatases ultimately 
requires elucidation of the mechanistic underpinnings of sub-
strate dephosphorylation. The available structural information 
for the PP2A holoenzymes greatly facilitates this undertaking, 
as exemplified by studies of the microtubule-binding protein 
Tau (Xu et al., 2008). Hyperphosphorylated Tau is thought to 
polymerize into neurofibrillary tangles in the brain and contrib-
utes to the onset of Alzheimer’s disease (Goedert and Spillan-
tini, 2006). A key function of PP2A is to dephosphorylate the 
hyperphosphorylated Tau protein (Bennecib et al., 2000; Gong 
et al., 2000; Kins et al., 2001) This activity appears to be medi-
ated by the B family of regulatory subunits (Drewes et al., 1993; 
Gong et al., 1994). Using an in vitro dephosphorylation assay 
and structure-guided mutagenesis, the respective binding ele-
ments in the B subunit and in Tau were identified (Xu et al., 
2008). This study uncovered two nonoverlapping fragments of 
Tau (both within the microtubule-binding repeats) that interact 
with the acidic top face of the B subunit (Figure 4E). Because 
Tau is frequently hyperphosphorylated on a number of amino 
acids throughout its primary protein sequences, the presence 
of two PP2A-binding elements likely allows Tau to efficiently 
target nearby phosphoresidues to the catalytic subunit.
Flexibility of the PP2A Scaffold Subunit
The limited packing interactions between adjacent HEAT 
repeats and the elongated shape of the scaffold subunit sug-
gest conformational flexibility. This property has been demon-
strated by structures of distinct PP2A complexes. Compared 
to the free scaffold subunit (Groves et al., 1999), HEAT repeats 
13–15 are shifted by 20–30 Å upon binding to the catalytic 
subunit, with the most drastic change between HEAT repeats 
12 and 13 (Xing et al., 2006). Compared to the core enzyme, 
formation of holoenzyme harboring the B′ subunit forces the 
N-terminal HEAT repeats to twist and move by as much as 
50–60 Å (Cho and Xu, 2006; Xu et al., 2006) (Figure 4F). These 
structural changes, originating from a five-residue sequence in 
HEAT repeat 11, rearrange the hydrophobic core both between 
and within the HEAT repeats. The remarkable conformational 
flexibility of the scaffold subunit likely underlies PP2A function 
and may be a prerequisite for binding to the catalytic and the 
regulatory subunits. Certain degrees of flexibility in the scaffold 
subunit may facilitate the phosphatase activity of the catalytic 
subunit through improved targeting of the substrate protein.
Reversible Methylation of PP2A
Reversible methylation of the PP2A core enzyme is a con-
served regulatory mechanism for PP2A function. Methyla-
tion of the C-terminal leucine 309 in a conserved TPDYFL309 
motif (D, aspartic acid; Y, tyrosine; L, leucine) of the catalytic 
subunit was shown to enhance the affinity of the PP2A core 
enzyme for some, but not all, regulatory subunits (Ikehara et 
al., 2007; Ogris et al., 1997; Tolstykh et al., 2000; Wei et al., 
2001; Xing et al., 2006; Xu et al., 2006, 2008). Thus, changes in 
Figure 5. Structure and Mechanism of PP5
(A) The structure of PP5 reveals a mechanism of 
autoinhibition. The C-terminal αJ helix (magenta) of 
PP5 binds to its N-terminal TPR domain (purple) and 
significantly strengthens the interaction between the 
tetratricopeptide repeat (TPR) domain, a protein-pro-
tein interaction motif, and the phosphatase domain 
(green). These interactions maintain PP5 in an inhibi-
tory state. The catalytic metal ions are colored red.
(B) Structure of the PP5 TPR domain bound to a 
high-affinity peptide (orange) derived from the pro-
tein chaperone Hsp90.
(C) The binding locations for the αJ helix and the 
Hsp90 peptide do not overlap with each other. 
However, the two conformations of the TPR do-
main bound to the αJ helix or the Hsp90 peptide 
are markedly different from each other. This allos-
tery may explain the mutual exclusion of αJ helix 
and the Hsp90 peptide binding.PP2A methylation might modulate the specificity and activity 
of PP2A in cells. Reversible methylation of PP2A is catalyzed 
by two conserved and PP2A-specific enzymes, leucine car-
boxyl methyltransferase (LCMT1) (De Baere et al., 1999; Lee 
and Stock, 1993) and PP2A methylesterase (PME-1) (Lee et al., 
1996). PME-1 catalyzes the removal of the methyl group, thus 
reversing the activity of LCMT1 (Lee et al., 1996).
Compelling evidence demonstrated that methylation plays an 
important, perhaps indispensable, role for the assembly of PP2A 
holoenzymes in cells (Bryant et al., 1999; Gentry et al., 2005; 
Kloeker et al., 1997; Longin et al., 2007a; Tolstykh et al., 2000; Wei 
et al., 2001; Wu et al., 2000; Yu et al., 2001). In these studies, forma-
tion of the PP2A holoenzyme was examined in cellular extracts. In 
contrast, several recent investigations relied on recombinant pro-
teins and demonstrated that methylation of the catalytic subunit 
was dispensable for the in vitro assembly of PP2A holoenzymes 
harboring the B or B′ subunits (Ikehara et al., 2007; Xu et al., 2006, 
2008). Neither mutation of the C-terminal leucine residue nor 
removal of the 14 C-terminal amino acids in the catalytic subunit 
prevented formation of heterotrimeric holoenzymes involving the 
B or B′ subunits (Ikehara et al., 2007; Xu et al., 2006, 2008). Other 
studies also suggested that methylation was not required for in 
vitro assembly of the PP2A holoenzyme involving the B′ subunit 
(Gentry et al., 2005; Longin et al., 2007a).
How can these seemingly conflicting observations be recon-
ciled? One potential explanation is that although methylation may 
not be required for the assembly of PP2A holoenzymes, it makes 
a contribution by enhancing binding affinity, which is sufficient to 
favor holoenzyme assembly in cells. Consistent with this notion, 
competitive binding experiments between methylated and unm-
ethylated PP2A core enzymes suggested that the methylated 
core enzyme exhibited a higher binding affinity for the B subunit 
in comparison to the unmethylated core enzyme (Xu et al., 2008). 
Another possibility is that methylation may serve as an assembly 
signal for the PP2A holoenzyme. The methylated C terminus of 
the catalytic subunit may allow it to be targeted to specific cellular 
location for holoenzyme assembly. In addition, the methylated C 
terminus may recruit other proteins that facilitate the assembly of 
the PP2A holoenzymes within the cell. Examination and charac-
terization of mutant mice that express a catalytic subunit lacking 
leucine 309 may give insight into the functional importance of the 
reversible methylation of PP2A in vivo.How does PME-1 regulate the activity of PP2A? Structural 
and biochemical analysis revealed two striking consequences 
for the formation of the heterotrimeric PME-1-PP2A complex 
(Xing et al., 2008) (Figure 4G). First, binding of the PP2A core 
enzyme to PME-1, which is catalytically inactive by itself, results 
in its activation through rearrangement of the catalytic triad, 
which consists of serine 156, aspartate 181, and histidine 349 
(Figures 4H and 4I). The side chain of histidine 349 translocates 
by 8 Å to be in register with aspartic acid 181 and serine 156 
(Figure 4I). The extensive interactions at the PME-1-PP2A inter-
face also lead to the enlargement of the active site pocket of 
PME-1 to accommodate the C-terminal peptide of the catalytic 
subunit. Second, the catalytic subunit of PP2A is inactivated 
by PME-1, not just through demethylation but also through the 
loss of the catalytic metal ions (Xing et al., 2008). In the struc-
ture, the two Mn2+ ions in the catalytic center of the PP2A core 
enzyme were dislodged, likely due to steric hindrance from the 
conserved residue methionine 335 in PME-1 (Xing et al., 2008). 
The biological significance of PME-1-mediated PP2A inacti-
vation in cells remains to be investigated (Longin et al., 2004, 
2007b).
The interaction between PME-1 and PP2A is subject to regu-
lation by an array of other PP2A-binding factors, including but 
not limited to LCMT1 and PTPA. In contrast to PME-1, which 
inactivates PP2A, PTPA and LCMT1 activate PP2A. Formation 
of a stable complex between PP2A and PME-1 probably blocks 
LCMT1-catalyzed methylation. Deletion of PTPA homologs 
(Rrd1/Rrd2) in yeast resulted in elevated levels of stable PP2A-
PME-1 complexes and decreased methylation (Hombauer et 
al., 2007). The dual roles of PME-1 in counteracting the func-
tion of PTPA and LCMT1 provide a mechanism for coupling 
PP2A activation with methylation. The opposing functions of 
PME-1 and PTPA might form a regulatory circuit for PP2A inac-
tivation and activation, likely through the removal and reloading 
of the catalytic metal ions.
Protein Phosphatase 5
Whereas most PPP family members have isoforms encoded by 
different genes, protein phosphatase 5 (PP5) is encoded by a 
single gene throughout Eukaryota. Another unique character-
istic of PP5 is that its regulatory and catalytic domains are all 
contained within the same polypeptide. PP5 is expressed in all Cell 139, October 30, 2009 ©2009 Elsevier Inc. 475
mammalian tissues examined, with high levels in the brain. It 
regulates cellular proliferation, differentiation, migration, sur-
vival and death, and DNA damage repair (Hinds and Sanchez, 
2008). In particular, PP5 plays an important role in hormone- 
and stress-induced signaling. For example, PP5 modulates 
glucocorticoid receptor (GR) signaling, which controls a range 
of physiological functions, including development, metabo-
lism, and reproduction, through direct interactions with the 
Hsp90-GR complex (Davies et al., 2005; Golden et al., 2008). 
GR proteins not associated with ligand are retained in the cyto-
plasm, whereas the binding of GR to glucocorticoid results in 
its release from the Hsp90 complex and subsequent translo-
cation into the nucleus, where it binds to DNA and modulates 
gene transcription.
PP5 contains a regulatory domain at its N terminus—the 
tetratricopeptide repeat (TPR) domain, a known protein-
protein interaction motif (Figure 1). Similar to calcineurin, the 
phosphatase activity of free PP5 is suppressed, because the 
TPR domain and a C-terminal helix αJ together maintain PP5 
in an autoinhibited conformation. Interactions with the TPR 
domain by Hsp90 and fatty acids such as arachidonic acid 
lead to release of autoinhibition. Structural analysis of human 
PP5 reveals that access to the active site of the phosphatase 
domain is blocked by the TPR domain (Yang et al., 2005) (Fig-
ure 5A). Association between the TPR domain and the phos-
phatase domain is strengthened by the αJ helix of PP5, which 
directly binds to a surface groove on the TPR domain. A peptide 
derived from Hsp90 interacted with the isolated TPR domain 
more tightly than with the intact PP5 protein, suggesting that 
the αJ helix partially blocks Hsp90 binding (Yang et al., 2005). 
This observation supports a mutual exclusion model, in which 
steric clash between Hsp90 and the αJ helix, upon binding to 
the TPR domain, was thought to be responsible for the release 
of PP5 autoinhibition (Yang et al., 2005). However, structural 
comparison of the TPR domain bound to a high-affinity Hsp90 
peptide (Figure 5B) with PP5 revealed no steric clash between 
the Hsp90 peptide and the αJ helix (Cliff et al., 2006). Hsp90 
binding appears to induce pronounced conformational shift in 
the TPR domain, especially in the α7 helix (Figure 5C), which 
may no longer be compatible with binding by the αJ helix (Cliff 
et al., 2006). This allosteric model is consistent with all pub-
lished evidence.
The ability of the TPR domain to undergo ligand-induced 
conformational change allows PP5 to respond to a number of 
cellular factors and thus may be crucial to PP5 function. For 
example, PP5 were found to interact, through its TPR domain, 
with the G proteins Gα12 and Gα13 (Yamaguchi et al., 2002) and 
the small GTPase Rac (Gentile et al., 2006). These interactions 
were found to stimulate the phosphatase activity of PP5, which 
subsequently modulates the cognate signaling processes. The 
phosphatase activity of the full-length PP5, but not the phos-
phatase domain, is stimulated by polyunsaturated, long-chain 
fatty acids such as arachidonic acid. Fatty acids, especially 
those with chain length of 16 carbon atoms or more, directly 
interact with the TPR domain. These interactions, such as 
those with arachidonoyl-CoA, were found to alter the confor-
mation of the PP5 TPR domain, which presumably results in 
the release of autoinhibition (Yang et al., 2005). Because cel-476 Cell 139, October 30, 2009 ©2009 Elsevier Inc.lular long-chain fatty acyl-CoA esters are known to play a role 
in the regulation of insulin secretion and gene expression, it is 
possible that such effects are in part mediated by activated 
PP5.
Protein Phosphatase 2C
PP2C and pyruvate dehydrogenase phosphatases belong to 
the Mn2+/Mg2+-dependent PPM family. In contrast to the PPP 
family phosphatases, PP2C is insensitive to inhibition by oka-
daic acid or microcystin. PP2C represents a large family of 
highly conserved protein phosphatases, with 16 distinct PP2C 
genes in the human genome that give rise to at least 22 differ-
ent isoforms (Lammers and Lavi, 2007). Plants contain even 
more PP2C genes, with 80 and 78 in the model plant Arabi-
dopsis thaliana and rice, respectively (Xue et al., 2008). The 
primary function of PP2C appears to be the regulation of stress 
signaling, although it also plays a role in cell differentiation, 
growth, survival, apoptosis, and metabolism (Lu and Wang, 
2008). Some PP2C members, such as PP2Cα, PP2Cβ, and PH 
domain leucine-rich repeat protein phosphatase (PHLPP), are 
candidate tumor suppressor proteins, whereas others, such 
as PP2Cδ (also known as Wip1), may contribute to oncogenic 
transformation.
The conserved catalytic core domain of human PP2C con-
tains a central β sandwich, with each β sheet flanked by a pair 
of α helices (Das et al., 1996) (Figure 6A). This arrangement 
Figure 6. Structure and Mechanism of PP2C
(A) The structure of PP2C, a metal-dependent protein phosphatase (PPM) 
family member, containing the phosphatase domain (cyan) and the C-terminal 
helical domain (yellow).
(B) Structure of the prokaryotic PPM homolog PphA from the bacterium Ther-
mosynechococcus elongates. In contrast to PP2C, three metal ions (magenta) 
are located in the active site. A surface loop (flap, orange) close to the active 
site was shown to play an important role in regulating substrate access to the 
catalytic center.
(C) The highly conserved metal binding coordination between mamma-
lian PP2C and phosphatase homologs from prokaryota. All residues (green) 
shown are from Thermosynechococcus elongates; residues (cyan) indicated 
in parentheses are from the human protein.
Figure 7. Structure and Mechanism of FCP/
SCP
(A) Recognition mechanism of a C-terminal domain 
(CTD) phosphopeptide from RNA polymerase II by 
the small CTD phosphatase (Scp1). The specific 
interactions mainly involve binding of the proline 
at the third position (Pro3) in the heptad repeat 
sequence YSPTSPS in the CTD by hydrophobic 
amino acids from Scp1 and the coordination of the 
phosphate group on the phosphorylated serine in 
the fifth position (pSer5) in the repeat by the Mg2+ 
ion.
(B) The structure of Fcp1 (TFIIF-associating com-
ponent of RNA polymerase II CTD phosphatase), 
which like Scp1 also dephosphorylates the CTD of 
RNA polymerase II, reveals a Y-shaped architec-
ture. The BRCT domain (cyan) of Fcp1 does not 
bind to the phosphopeptide as previously thought. 
Rather, the CTD peptide is likely accommodated 
by the deep canyon between the two arms of the 
Y-shaped molecule.generates a cleft between the two β sheets, with the two metal 
ions located at the base of the cleft. Each metal ion is hexa-
coordinated by amino acids and water molecules. Similar to 
members of the PPP family, dephosphorylation is thought 
to involve nucleophilic attack of the phosphorous atom by a 
metal-activated water nucleophile through an SN2 mechanism. 
Three additional α helices, unique to PP2C, associate with the 
core domain on one side (Figure 6A) and may contribute to 
substrate specificity or regulation.
Genome analysis of the bacterial kingdom, particularly 
cyanobacteria, revealed a large number of PPM homologs (Shi, 
2004; Zhang et al., 2005; Zhang and Shi, 2004). This observation 
suggests that reversible protein serine/threonine phosphoryla-
tion may play an important role in bacterial physiology. Struc-
tural analysis of these PPM homologs has been performed for 
PphA from Thermosynechococcus elongates (Schlicker et al., 
2008) (Figure 6B), PstP from Mycobacterium tuberculosis (Pullen 
et al., 2004), MspP from Mycobacterium smegmatis (Bellinzoni 
et al., 2007; Wehenkel et al., 2007), and SaSTP from Streptococ-
cus agalactiae (Rantanen et al., 2007). The structures of these 
PPM homologs are nearly identical to that of the phosphatase 
core domain of human PP2C (Figures 6A and 6B), with the active 
site residues highly conserved (Figure 6C). Compared to human 
PP2C, two notable differences are the presence in these bacte-
rial PPM homologs of a third metal ion and a loop above the 
active site (thought to regulate substrate binding and catalysis).
Despite recent progress, much remains to be learned about 
the molecular mechanism of PP2C. Unlike the PPP family, PP2C 
has a large number of isoforms encoded by different genes. The 
different isoforms have distinct sequences and domain organi-
zations. These PP2C isoforms also exhibit distinct functions, 
expression patterns, and subcellular localization. How these iso-
forms are regulated during signaling remains largely unknown. 
The molecular determinants of substrate specificity for the vari-
ous PP2C isoforms also remain to be elucidated. For example, in addition to the conserved PP2C phosphatase domain, PHLPP 
also contains an N-terminal PH domain and a leucine-rich repeat 
(LRR) domain (Brognard et al., 2007; Gao et al., 2005). PHLPP 
and PHLPP2 are thought to promote apoptosis and suppress 
tumor growth through dephosphorylation of distinct Akt isoforms 
(Brognard et al., 2007; Gao et al., 2005). But how the additional PH 
and LRR domains may contribute to the phosphastase activity 
and substrate specificity remains unclear.
FCP/SCP and Chronophin
In contrast to all other protein Ser/Thr phosphatases dis-
cussed herein, members of the FCP/SCP family rely on the 
aspartic acids of the sequence motif DxDxT/V for phos-
phatase activity. Another unusual feature is that FCP/SCP 
has only one primary substrate—the CTD of RNA poly-
merase II, which contains tandem repeats of the sequence 
YSPTSPS. There are eight putative CTD phosphatases in 
the human genome (Zhang et al., 2006). Both the level and 
the pattern of the CTD phosphorylation oscillate with cycles 
of transcription, with hypophosphorylation in the preinitia-
tion complex and hyperphosphorylation during transcrip-
tion elongation. Phosphorylated serine 5 (pSer5), the ser-
ine at the fifth position in the tandem repeat, is enriched 
at transcription initiation and early transcription elongation, 
whereas phosphorylation of the serine at the second posi-
tion in the tandem repeat (pSer2) is favored during transcrip-
tion elongation and through the end of transcription. Distinct 
patterns of phosphorylation in the CTD are assessed by 
regulatory proteins for binding (Fabrega et al., 2003; Glover-
Cutter et al., 2008; Ho and Shuman, 1999) throughout tran-
scription and constitute the so-called “CTD code” (Bura-
towski, 2003). Fcp1 is the main serine phosphatase for the 
CTD and can dephosphorylate both pSer2 and pSer5. Fcp1 
from the fission yeast Schizosaccharomyces pombe favors 
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factor of about 6-fold (Hausmann et al., 2004). In contrast, 
Scp1 exhibits little activity for pSer2 and prefers pSer5 by a 
factor of 70-fold (Zhang et al., 2006).
Structural analysis reveals that Scp1 forms an α/β fold, with 
a central five-stranded β sheet (Kamenski et al., 2004; Zhang 
et al., 2006) (Figure 7A). Despite a lack of detectable sequence 
homology, the Scp1 protein core resembles that of the phos-
phoserine phosphatase from Methanococcus jannaschii (Wang 
et al., 2001), β-phosphoglucomutase from Lactococcus lactis 
(Lahiri et al., 2003), the Bacteroides hexose phosphate phos-
phatase (Lu et al., 2008), and haloacid dehalogenase (HAD) 
from Xanthobacter autotrophicus (Ridder et al., 1999). The sig-
nature motif DxDxT is located C-terminal to the first β strand of 
the conserved core domain. A three-stranded β sheet, termed 
the insertion domain, immediately follows the DxDxT motif. The 
close proximity of the insertion domain to the catalytic aspar-
tate residues suggests a potential role for the region in cataly-
sis. Consistent with this notion, a pSer5-containing CTD pep-
tide is bound to the cleft between the insertion domain and the 
core domain (Zhang et al., 2006) (Figure 7A). The recognition 
specificity is mainly provided by Mg2+-mediated coordination 
of the phosphate group of pSer5 and interaction of the pro-
line at the third position in the repeat (Pro3) with hydrophobic 
amino acids from the insertion domain (Figure 7A, right panel). 
This mode of binding provides a plausible explanation for why 
Scp1 favors pSer5 over pSer2.
Fcp1 forms a Y-shaped structure, with the conserved FCPH 
domain as the base and bottom stem (Ghosh et al., 2008) (Fig-
ure 7B). The single BRCT domain forms one arm, and the inser-
tion domain, which contains four extra α helices compared to 
Scp1, constitutes the other arm. This architecture generates a 
deep canyon at the center of Fcp1, with the DxDxT motif and 
the bound Mg2+ ion at the base of the canyon. The structural 
arrangement excludes the possibility that the CTD peptide may 
bind to the same location in Fcp1 as in Scp1. Biochemical and 
structural analysis strongly argues that the canyon between 
the two arms of Fcp1 may accommodate the CTD substrate 
(Ghosh et al., 2008).
The catalytic mechanism of Fcp1/Scp1 may involve two 
sequential steps (Ghosh et al., 2008; Kamenski et al., 2004). 
First, an oxygen atom from the carboxylate group of the N-ter-
minal aspartate in the DxDxT motif initiates a nucleophilic attack 
on the phosphorous atom of a pSer, forming an acylphosphate 
intermediate. Second, a water nucleophile, likely activated by 
the second aspartate in the DxDxT motif, attacks the phospho-
rous atom of the acylphosphate intermediate, resulting in the 
release of an inorganic phosphate. Mg2+ is thought to facilitate 
both steps of the reaction by neutralizing the negative charges 
of the phosphate group. It is important to note that the role of 
the metal ion (Mg2+) in Fcp1/Scp1 is different from that in the 
PPP or PPM family, where the metal ions are directly involved 
in catalysis through the activation of a water nucleophile.
Chronophin, a member of the HAD family, is also an aspar-
tate-based PSP (Gohla et al., 2005). Like FCP/SCP, it contains 
the signature sequence motif DxDxT and has a similar active 
site (PDB code 2CFR). Another striking similarity between FCP/
SCP and chronophin is that they each have only one known 
substrate protein. Chronophin dephosphorylates pSer3 of 478 Cell 139, October 30, 2009 ©2009 Elsevier Inc.cofilin, an important regulator of actin dynamics, leading to its 
activation (Gohla et al., 2005). The mechanisms by which chro-
nophin recognizes and dephosphorylates cofilin remain to be 
elucidated.
Other Protein Ser/Thr Phosphatases
This review focuses on the PSPs for which structural informa-
tion is available. Some of the other PSPs share considerable 
sequence similarity with the structurally characterized PSPs 
and are expected to exhibit similar structural features. For exam-
ple, the catalytic subunits of PP4 and PP6 are closely related 
to the catalytic subunit of PP2A (Figure 1). Both PP4 and PP6 
are essential PSPs in all eukaryotic species and are thought to 
regulate a diverse range of cellular functions independently of 
PP2A (Cohen et al., 2005; Kajino et al., 2006; Mi et al., 2009; Ste-
fansson and Brautigan, 2007). In analogy to PP2A, the catalytic 
subunit of PP6 is thought to form a heterotrimeric holoenzyme, 
with a Sit4-associated protein (SAP) domain-containing scaffold 
subunit and an ankyrin repeat subunit that likely serves as the 
regulatory subunit (Stefansson et al., 2008). The catalytic sub-
unit of PP4 also associates with its own regulatory subunits R1 
and R2 to form distinct complexes (Cohen et al., 2005). In con-
trast to PP4 and PP6, PP7 appears to be unique to plants. Unlike 
other members of the PPP family, PP7 contains three insertions 
in its phosphatase domain, and the recombinant PP7 protein 
gained phosphatase activity only after cleavage of the longest 
insertion, suggesting an autoinhibitory role (Kutuzov et al., 1998). 
PP7 was shown to interact with Ca2+-CaM, but in contrast to 
calcineurin, this interaction appears to inhibit the phosphatase 
activity of PP7 (Kutuzov et al., 2001).
There are also other unique PSPs. For example, protein 
phosphatases with kelch-like repeats (PPKLs) contain a C-ter-
minal domain, a PP1-related Ser/Thr phosphatase domain, 
and a predicted N-terminal β-propeller domain comprising 
multiple kelch-like repeats (Kutuzov and Andreeva, 2002). The 
kelch repeats are likely involved in substrate recognition and 
interaction with other proteins. PPKLs have been identified in 
plants, green algae, and parasites (Moorhead et al., 2009). The 
function and molecular mechanisms of PPKLs remain largely 
uncharacterized.
Perspective
Many features of PSPs are different from those of PTPs. In 
contrast to PSPs, 99 of the 107 PTPs in the human genome 
are cysteine-based phosphatases, which are likely evolved 
from a common ancestor and share a similar structure for the 
phosphatase domain (Alonso et al., 2004). Consequently, the 
catalytic mechanisms of the metal-dependent PSPs—PPP 
and PPM—differ from those of the cysteine-based PTPs. Most 
PTPs contain one or more additional domains, which medi-
ate interactions with other proteins and/or phospholipids. The 
single-chain, multidomain feature of PTPs, which may afford 
stringent specificity and tight regulation, contrasts with the 
multisubunit characteristic of most PSPs that likely generates 
greater substrate diversity and flexibility.
Phosphorylation primarily occurs on serine, threonine, and 
tyrosine residues in eukaryotic proteins. In contrast, prokary-
otic proteins, such as those of the bacterial two-component 
signaling systems, were thought to be mainly phosphorylated 
on histidine and aspartic acid residues. Recent phosphopro-
teomic analyses, however, have revealed widespread phos-
phorylation on serine, threonine, and tyrosine residues in many 
essential proteins of both Gram-positive and Gram-negative 
bacteria (Macek et al., 2007, 2008; Soufi et al., 2008). These 
observations, together with the finding that bacteria contain 
a number of PPM-like Ser/Thr phosphatases, suggest a criti-
cal role for serine/threonine/tyrosine phosphorylation and 
dephosphorylation in the prokaryotic life cycle. Discovery of 
Ser/Thr-specific and Tyr-specific kinases and phosphatases 
in bacteria and characterization of their activities are likely to 
reveal additional principles of bacterial signaling.
In the human genome, the number of genes encoding the 
catalytic subunit of protein Ser/Thr phosphatases is much 
smaller than the number of genes that encode protein Ser/Thr 
kinases. In this regard, how can the PSPs ensure specificity 
in cell signaling? The answer to this question appears to be 
straightforward for the PPP family of phosphatases. Through 
association with multiple regulatory subunits and other inter-
acting proteins, each catalytic subunit gains the ability to form 
a large number of different holoenzymes, each with potentially 
distinct substrate specificity. This scenario is exemplified by 
PP1, which has more than 100 R subunits, and by PP2A, which 
has a unique tripartite organization. The scaffold and the cata-
lytic subunits of PP2A are each encoded by two genes, giving 
rise to the α and β isoforms; the regulatory subunits of PP2A 
comprise four families, each also encoded by several genes. 
Together, the combination of these three subunits generates 
a large number of heterotrimeric PP2A holoenzymes, each 
of which could serve a distinct function. For example, the δ 
isoform of the B′ subunit is involved in dephosphorylation of 
Cdc25, which is required for its sequestration by the adaptor 
protein 14-3-3 in DNA-responsive checkpoints (Margolis et al., 
2006). The release of Cdc25 would lead to activation of Cdc2/
CyclinB and cell-cycle progression. In contrast, B′α specifically 
associates with and dephosphorylates the proto-oncogene 
c-Myc, resulting in its degradation (Arnold and Sears, 2006). 
In addition, other interacting proteins may help target PP2A to 
specific cellular locations and thus further enhance substrate 
specificity. Recent biochemical and structural characterization 
suggests that shugoshin-mediated recruitment of PP2A to the 
centromere might be solely intended for the dephosphorylation 
of cohesin, thereby preventing cleavage of cohesin by separase 
during meiosis I to prevent premature sister chromatid separa-
tion (Xu et al., 2009). Supporting this notion, shugoshin binding 
did not affect the dephosphorylation of peptide substrate (Xu 
et al., 2009). Identification of specific PP2A holoenzyme(s) or 
other PSPs and their targeting/interacting proteins in specific 
cellular processes is only beginning and will likely have a major 
impact on mechanistic understanding of cellular physiology.
Structure underlies function and its elucidation can reveal 
mechanism. Recent biochemical and structural investiga-
tion of protein Ser/Thr phosphatases has given considerable 
insight into the mechanisms that underlie their assembly, acti-
vation, catalysis, substrate recognition, and regulation. Despite 
these advances, comprehensive mechanistic understanding is 
far from complete. There are major unanswered questions for every family or subfamily of PSPs. What we know today likely 
represents only a small proportion of what is required to have 
a comprehensive understanding on the function and mecha-
nisms of PSPs. First, structural and mechanistic character-
ization of the core components of PSPs remains preliminary. 
For example, despite the elegant work on the PP1-MYPT1 
complex, we do not yet have a general understanding of the 
mechanisms by which the R subunits modulate the function 
and activity of the PP1 catalytic subunit. We also do not yet 
understand the mechanisms by which Ca2+-CaM binds and 
activates calcineurin. We have no structural information on the 
B′′ family of regulatory subunits or its complex with the PP2A 
core enzyme. Second, mechanistic information regarding the 
recognition and dephosphorylation of specific substrate pro-
tein is scant. In fact, the physiological substrate proteins for 
most PSPs remain to be identified, and this is a major current 
focus of the phosphatase field. At present, only a few struc-
tures of PSPs bound to substrate peptide have been eluci-
dated; there is no structural information available for a PSP 
bound to a phosphoprotein substrate. Third, beyond the regu-
latory subunits, although PSPs interact with a large number 
of cellular and viral proteins, the mechanisms by which PSPs 
are regulated by these proteins remain largely enigmatic. For 
example, it is still unclear how the antiapoptosis protein α4 
modulates the activity and specificity of PP2A through compe-
tition with the scaffold subunit (Kong et al., 2004; Prickett and 
Brautigan, 2004). However, the structure of Tap42, the α4 pro-
tein in Saccharomyces cerevisiae, has revealed that the pro-
tein has a TPR-like fold and allowed the identification of amino 
acids that are important for binding to PP2A (Yang et al., 2007). 
One of the few well-characterized examples of PSP interaction 
with viral proteins involves the small t antigen of SV40, which 
specifically inhibits the phosphatase activity of the PP2A core 
enzyme and interferes with recruitment of the regulatory sub-
units (Chen et al., 2007; Cho et al., 2007; Pallas et al., 1990; 
Walter et al., 1990).
At a more specific level, little is known about the regulation 
of phosphatase activity or specificity by the regulatory sub-
units of PSPs. Existing evidence suggests that some PSPs 
may exhibit phosphotyrosine phosphatase activity under 
some circumstances. For example, PP2A was found to have 
a basal level of phosphotyrosine phosphatase activity, and 
PTPA stimulated this activity by more than 10-fold while sup-
pressing the phosphoserine/phosphothreonine phosphatase 
activity of PP2A (Cayla et al., 1990; Chao et al., 2006; Van 
Hoof et al., 1994). How PTPA accomplishes this remains to be 
investigated, although available evidence showed that PTPA 
and the PP2A core enzyme form a composite ATPase. Within 
this ATPase, ATP hydrolysis was required for the enhanced 
phosphortyrosine phosphatase activity of PP2A (Cayla et al., 
1990; Chao et al., 2006). Other studies suggested that PTPA 
might function as a cis-trans prolyl isomerase with specific-
ity for a conserved proline residue close to the active site of 
the PP2A catalytic domain (Jordens et al., 2006; Leulliot et al., 
2006). Because the observed PTPA prolyl isomerase activity 
was stimulated by Mg2+/ATP, it is possible that prolyl isomer-
ization, fueled the ATP hydrolysis, may be responsible for the 
altered substrate specificity through conformational changes Cell 139, October 30, 2009 ©2009 Elsevier Inc. 479
in the active site. Regardless of the exact mechanism, these 
observations raise the question of whether PP2A can ever be 
a physiologically meaningful PTP in cells and, if so, under what 
cellular context. As PP2A is highly conserved from yeasts to 
mammals, it remains to be seen whether there are conserved 
phosphotyrosine substrate proteins for PP2A.
The regulation and function of PSPs may turn out to be more 
complex as regulatory subunits are characterized in greater 
detail. Nonetheless, the principal conclusion derived from such 
studies is unlikely to change, that is, both the activity and the 
phosphatase specificity of PSPs are subject to regulation in 
response to the formation of a wide variety of distinct com-
plexes.
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